Literature DB >> 24670410

Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin.

Arif B Ekici1, Thomas Hackenbeck2, Vincent Morinière3, Andrea Pannes4, Maike Buettner5, Steffen Uebe1, Rolf Janka6, Antje Wiesener1, Ingo Hermann2, Sina Grupp2, Martin Hornberger7, Tobias B Huber8, Nikky Isbel9, George Mangos10, Stella McGinn11, Daniela Soreth-Rieke12, Bodo B Beck4, Michael Uder6, Kerstin Amann5, Corinne Antignac13, André Reis1, Kai-Uwe Eckardt14, Michael S Wiesener2.   

Abstract

For decades, ill-defined autosomal dominant renal diseases have been reported, which originate from tubular cells and lead to tubular atrophy and interstitial fibrosis. These diseases are clinically indistinguishable, but caused by mutations in at least four different genes: UMOD, HNF1B, REN, and, as recently described, MUC1. Affected family members show renal fibrosis in the biopsy and gradually declining renal function, with renal failure usually occurring between the third and sixth decade of life. Here we describe 10 families and define eligibility criteria to consider this type of inherited disease, as well as propose a practicable approach for diagnosis. In contrast to what the frequently used term 'Medullary Cystic Kidney Disease' implies, development of (medullary) cysts is neither an early nor a typical feature, as determined by MRI. In addition to Sanger and gene panel sequencing of the four genes, we established SNaPshot minisequencing for the predescribed cytosine duplication within a distinct repeat region of MUC1 causing a frameshift. A mutation was found in 7 of 9 families (3 in UMOD and 4 in MUC1), with one indeterminate (UMOD p.T62P). On the basis of clinical and pathological characteristics we propose the term 'Autosomal Dominant Tubulointerstitial Kidney Disease' as an improved terminology. This should enhance recognition and correct diagnosis of affected individuals, facilitate genetic counseling, and stimulate research into the underlying pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24670410     DOI: 10.1038/ki.2014.72

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Personalized medicine in chronic kidney disease by detection of monogenic mutations.

Authors:  Dervla M Connaughton; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2020-03-01       Impact factor: 5.992

Review 2.  From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis.

Authors:  Gopalakrishnan Venkat-Raman; Christine Gast; Anthony Marinaki; Lynnette Fairbanks
Journal:  Pediatr Nephrol       Date:  2016-02-12       Impact factor: 3.714

Review 3.  Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Authors:  Emilie Cornec-Le Gall; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

Review 4.  Uromodulin: from physiology to rare and complex kidney disorders.

Authors:  Olivier Devuyst; Eric Olinger; Luca Rampoldi
Journal:  Nat Rev Nephrol       Date:  2017-08-07       Impact factor: 28.314

5.  A multiplex method for detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations.

Authors:  L Zhang; Y Yang; R Liu; Q Li; F Yang; L Ma; H Liu; X Chen; Z Yang; L Cui; Y He
Journal:  Int J Lab Hematol       Date:  2015-07-20       Impact factor: 2.877

6.  Testing for the cytosine insertion in the VNTR of the MUC1 gene in a cohort of Italian patients with autosomal dominant tubulointerstitial kidney disease.

Authors:  Claudio Musetti; Deepak Babu; Ileana Fusco; Simona Mellone; Andrea Zonta; Marco Quaglia; Vincenzo Cantaluppi; Piero Stratta; Mara Giordano
Journal:  J Nephrol       Date:  2016-03-04       Impact factor: 3.902

7.  Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.

Authors:  Mingzhu Nie; Manjot S Bal; Zhufeng Yang; Jie Liu; Carolina Rivera; Andrea Wenzel; Bodo B Beck; Khashayar Sakhaee; Denise K Marciano; Matthias T F Wolf
Journal:  J Am Soc Nephrol       Date:  2016-04-01       Impact factor: 10.121

8.  Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition.

Authors:  Karl X Knaup; Thomas Hackenbeck; Bernt Popp; Johanna Stoeckert; Andrea Wenzel; Maike Büttner-Herold; Frederick Pfister; Markus Schueler; Didem Seven; Annette M May; Jan Halbritter; Hermann-Josef Gröne; André Reis; Bodo B Beck; Kerstin Amann; Arif B Ekici; Michael S Wiesener
Journal:  J Am Soc Nephrol       Date:  2018-07-26       Impact factor: 10.121

9.  Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Authors:  Kai-Uwe Eckardt; Seth L Alper; Corinne Antignac; Anthony J Bleyer; Dominique Chauveau; Karin Dahan; Constantinos Deltas; Andrew Hosking; Stanislav Kmoch; Luca Rampoldi; Michael Wiesener; Matthias T Wolf; Olivier Devuyst
Journal:  Kidney Int       Date:  2015-03-04       Impact factor: 10.612

10.  Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA.

Authors:  Daan Viering; Karl P Schlingmann; Marguerite Hureaux; Tom Nijenhuis; Andrew Mallett; Melanie M Y Chan; André van Beek; Albertien M van Eerde; Jean-Marie Coulibaly; Marion Vallet; Stéphane Decramer; Solenne Pelletier; Günter Klaus; Martin Kömhoff; Rolf Beetz; Chirag Patel; Mohan Shenoy; Eric J Steenbergen; Glenn Anderson; Ernie M H F Bongers; Carsten Bergmann; Daan Panneman; Richard J Rodenburg; Robert Kleta; Pascal Houillier; Martin Konrad; Rosa Vargas-Poussou; Nine V A M Knoers; Detlef Bockenhauer; Jeroen H F de Baaij
Journal:  J Am Soc Nephrol       Date:  2021-10-04       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.